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*Respiratory Division, Department of Medicine and ?-Emergency Department, University of British Columbia, 
Vancouver Hospital and Health Sciences Centre, Vancouver, British Columbia, Canada 
Objectives: To determine the female:male ratio and compare the severity of asthma between female and male 
patients presenting with acute asthma to the authors’ emergency department (ED). 
Patients: Patients aged 15-50 years presenting with acute asthma. 
Setting: Emergency department of a university-affiliated hospital. 
Methods: Retrospective analysis of asthma surveillance data and medical records of all asthma-related visits 
to ED over 6 months (January 1992-June 1992). 
Results: One hundred and thirty-seven patients aged 15-50 years made 196 consecutive visits to the authors’ 
ED over 6 months. The ratio of female:male patients was 1.9 and the ratio of the number of visits made by 
female vs. male patients was 2.6. Initial peak expiratory flow rate (PEFR) and forced expiratory volume in 1 s 
(FEV,) were recorded in 94% and 49% of the visits, respectively. There was no statistically significant 
difference between the male and female patients in heart rate, respiratory rate or percentage of patients 
admitted to hospital. The mean (SD) initial FEV, as a percentage of predicted was significantly higher in 
females compared to males (49% + 20% W. 33% * 15%; P<O.OOl). 
Conclusion: In the authors’ institution there is a high female:male ratio among patients presenting with acute 
asthma, and males tend to present later or with more severe disease. These findings need to be confirmed by 
a prospective study looking at all the factors that may contribute to asthma patients presenting to the ED. 
Introduction 
Acute asthma is a common medical emergency. 
Over the last 20 yr there have been several reports on 
the changing morbidity and mortality from bronchial 
asthma (1,2). Most studies of the prevalence of 
asthma in children in different parts of the world 
have found a male preponderance (3). Gender differ- 
ences in the incidence and prevalence of asthma in 
adults have not been recognized until recently. Rates 
of hospital admissions for asthma in Canada during 
the 1980s were consistently 50% higher among boys 
aged less than 15 years of age, compared to girls of 
that age; the rates among people aged 15-34 years 
were twice as high among females as males (4). In a 
longitudinal cohort study in Britain of the cumulative 
incidence of bronchial asthma, a similar phenomenon 
was observed (5). There are no reports on gender 
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differences in emergency department (ED) visits 
for asthma. This paper reports the clinical and 
spirometry findings of all patients presenting with 
acute asthma to the authors’ ED over 6 months, with 
emphasis on the difference between female and male 
patients. 
Methods 
As a part of an ongoing prospective surveillance, a 
standardized data sheet was completed for each 
patient presenting to Vancouver Hospital ED and 
diagnosed as having acute asthma. The data sheet 
was completed by a designated research nurse. A 
research nurse was available in the ED for 
20 h day - ‘, 6 days week- I, and patients presenting 
outside these hours had their data recorded from 
ED records. Data extracted included demographics, 
clinical characteristics, treatment received in the ED 
and final disposition, peak expiratory flow rate 
(PEFR) and forced expiratory volume in 1 s (FEV,), 
if measured. Data for the period January 1992 to 
June 1992 were examined. To confirm these data, 
medical records were also reviewed. The analysis was 
0 1996 W. B. Saunders Company Ltd 
486 N. Awadh et al. 
Table I Demographics and clinical characteristics of the two groups 
Females Males 
(n=88) (n=47) P 
Age (years) mean (SD) 
Duration of asthma (years) 
Duration of symptoms: < 1 day 
Duration of symptoms: > 1 day 
% of patients with rapid onset of symptoms: ~24 h 
% of smokers 
Heart rate mean (SD) 
Respiratory rate 
No. (%) of visits leading to admission 
30.5 (10.4) 
10.6 (9.4) 
4.9 (50) h 
4.3 (4.0) days 
45% 
28% 
96.6 (19.3) 
24.9 (7.6) 
7 (13%) 
32.4 (9.4) 
12.6 (10.8) 
3.3 (3.3) h 
4.8 (5.7) days 
33% 
28% 
96.6 (20.9) 
22.6 (5.7) 
15 (12.1%) 
n.s. 
ns. 
ns. 
ns. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s. 
n.s., not significant. 
limited to patients aged 15-50 years to avoid 
possible contamination by patients with chronic 
obstructive lung disease. Peak expiratory flow rate 
was measured with a mini-Wright peak flow meter. 
FEV, was measured by a Roxon pocket spirometer 
(Micromedical Ltd., Rochester, Kent, U.K.) Three 
measurements were taken and the best one was 
recorded. These measurements were taken by either a 
respiratory therapist or a research nurse. 
All statistical analyses were done using Systat 
(Systat Inc., Evanston, Illinois, U.S.A.). All con- 
tinuous variables were compared using Student’s 
t-test. Categorical variables were compared using 
chi-square. A P value of ~0.05 was considered 
significant. 
Results 
Over the 6-month period, 137 patients (89 females) 
made 196 consecutive visits for acute asthma to the 
ED. Two patients were excluded from analysis 
because both had a significant co-morbid condition 
which the authors felt contributed to their frequent 
visits. Both of these patients were females; one had 
poliomyelitis and the other had difficult psycho-social 
problems related to intravenous drug abuse. Each of 
these two patients made nine visits to the ED during 
the 6-month period. The ratio of female:male patients 
was 1.9, and the ratio of the number of visits made by 
females vs. male patients was 2.6. There were no 
statistically significant differences between females 
and males in age, duration of asthma, duration of 
acute symptoms, percentage of smokers, heart rate, 
respiratory rate, treatment received in the ED, or 
percentage of patients admitted to hospital (Table 1). 
All patients were taking either regular or ‘as 
needed’ inhaled bronchodilators prior to presen- 
tation. Forty-nine women (55%) were taking either 
inhaled or systemic steroid prior to presentation, 
while only 16 men (33%) were taking these medi- 
cations prior to presentation, P (0.04). There was no 
difference in theophylline intake between the two 
groups, 20% for females vs 19% for males. There was 
no difference between the two groups in terms of the 
classes of drugs given in the ED. However, the 
number of doses of bronchodilators given to each 
patient was not calculated. Although there was no 
statistically significant difference in absolute or per- 
centage of predicted PEFR at presentation between 
the two groups, FEV, at presentation was signifi- 
cantly higher among female patients (Table 2). The 
mean initial FEV, was 1.55 1, 49% of predicted 
(SD 20%) for females vs. 1.29 1, 33% (SD 15%) for 
males, P<O.OOl (Fig. 1). In a second analysis, the 
visit that had the worst FEV, only was included. By 
doing so, the mean FEV, for females decreased from 
49% to 47%. However, the difference compared to 
the males still remained significant (Table 2). The 
difference in FEV, between the two groups remained 
significant at disposition which included the patients 
who were discharged from the ED or admitted to 
hospital (Fig. 2). The mean FEV, at disposition was 
2.2 1, 68% of predicted (SD 20%) for females vs. 2.4 1 
58% (SD 19%) for males. 
Discussion 
The present study shows that, in the authors’ 
institution, there are almost twice as many females 
compared to males presenting with acute asthma, 
The study also suggests that males tend to present 
later, or with more severe disease. 
There are several studies (6,7) which showed con- 
sistently that the prevalence of childhood asthma is 
higher among boys than girls. Unlike childhood 
asthma, the prevalence of asthma among adults has 
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Table 2 Pulmonary function studies of the two groups 
Percentage Females Males 
recorded (n=88) (n=47) P 
PEFR at presentation 94 215 (*97) 241 (& 127) n.s., P=O.2 
PEFR at presentation as % predicted 80 46% ( zk 20%) 40% (zk 20%) n.s., P=O,ll 
FEV, * at presentation (all visits) 49 49% (zk 20%) 33% ( f 15%) 0.001 
FEV, at presentation (one visit per patient) 54 47% ( * 19%) 32% ( rt 14%) 0,001 
FEV, at dispositionf 43 68% (*20%) 58% (dz 19%) 0.03 
FEV, at discharge from ED 39 71% (zk 19%) 62% ( + 18%) n.s., P=O.O8 
PEFR, peak expiratory flow rate; FEV1, forced expiratory volume in 1 s; ED, emergency department; n.s., not significant. 
*All FEV, are shown as % of predicted. TDischarge from ED or admission to hospital. 
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Fig. I Box plots of FEV, at presentation. 
not been studied exclusively. There are two recent 
studies from Canada which indicate that rates of 
hospital admission for asthma and prevalence of 
physician-diagnosed asthma is higher in females than 
males in people more than 15 years of age. Wilkins 
and Mao (4) showed that the rate of hospital 
admission for asthma across Canada increased by 
about 46% from 1980 to 1988 in people aged 15-34 
years. Over the same period, the rate of hospital 
admission was twice as high for females as for males 
in that age group. Manfreda et al. (8) showed that 
the prevalence of physician-diagnosed asthma in the 
province of Manitoba between 1980 and 1990 was 
1.1-1.4 times higher for females than for males in 
the age group 15-54 years. For people older than 
55 years, there was little difference in the prevalence 
between male and female subjects. This is not a 
unique phenomenon in Canada. Anderson et al. (5), 
in a British study, showed that the male:female ratio 
of the cumulative incidence of asthma and wheezy 
bronchitis rose from 1.23 in the O-7 years period to 
1.48 at 12-16 years, but reversed to 0.5 at 17-23 years 
of age. In a retrospective analysis of 33 269 admis- 
sions for bronchial asthma to 67 hospitals in South- 
eastern Pennsylvania, Skobeloff et al. (9) found that 
between 20 and 50 years of age, the female:male ratio 
was nearly 3: 1. 
The present results of female:male ratio in ED 
visits for asthma is in keeping with the recent reports 
of the incidence and prevalence of asthma among 
young adults. What is more difficult to explain is the 
difference in severity of asthma at presentation as 
judged by FEV, between females and males. This was 
a consistent finding when the data for all the visits 
and the data for one visit per patient were analysed. 
Although this was a retrospective analysis, most of 
the data were collected prospectively as part of an 
ongoing surveillance of visits for asthma to the ED. 
The two groups were similar in age, duration of 
asthma and smoking history which rules out poten- 
tial confounding variables. There were more females 
who were taking either systemic or inhaled steroids 
prior to presentation, which may explain the differ- 
ence in severity seen at presentation. In the present 
study, the authors could not determine if the differ- 
ence in medication taken by the two groups was due 
to a difference in prescribing among primary care 
physicians or due to a difference in compliance by the 
patients. There was no statistically significant differ- 
ence in PEFR (both in absolute number and as 
percentage of predicted) between females and males. 
However, PEFR is more effort dependent and the 
predicted normal values have not been well standard- 
ized. FEV, data were only available for 54% of the 
study population. This may have created a bias as 
patients with more severe disease may be more likely 
to have their FEV, measured. To examine this more 
carefully, PEFR of the group of patients who had 
their FEV, measured were compared to those who 
did not have their FEV, measured. For female 
patients, the mean PEFR at presentation for the 
group who had their FEV, measured was 
2161min-’ (SD 871min-‘) vs. 215lmin-’ (SD 
111 1 min - ‘) for the group who did not. For male 
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Fig. 2 Graph showing the mean and the range of FEV, at presentation and disposition (discharge from emergency 
department or admission to hospital). 0, low; 0, high; W, average. 
patients, the mean PEFR at presentation for the 
group who had their FEV, measured was 
2021min~’ (SD 103 lmin-‘) vs. 246 lmin-’ (SD 
141 1 min ~ ‘) for the group who did not; P=O.23. 
This subgroup analysis showed a trend towards 
higher PEFR in male patients who did not have their 
FEV, measured. However, the difference was not 
statistically significant. FEV, was measured in 55% 
of female patients and 49% of male patients. The 
present findings are different from Skobeloff et al. (9) 
who concluded that female asthmatic subjects may be 
more severely affected by asthma than male subjects. 
This conclusion was based on length of hospital 
stay rather than any clinical or spirometric data. 
Skobeloff et al. (9) raised the possibility that hor- 
monal or biochemical differences related to gender 
may play a role in the pathogenesis or severity of 
asthma. In the present study, data about the timing 
of the acute exacerbations in relation to the 
menstrual cycles in female subjects were not 
available. 
The reasons for this apparent difference in the 
severity of asthma are not clear. One hypothesis is 
that males and females differ in the perception of 
dyspnoea in acute asthma. In a setting of airway 
obstruction induced by methacholine challenge test, 
Rubinfeld and Pain (10) showed that individual 
subjects reported chest tightness at a reproducible 
level of airflow obstruction. However, there was 
considerable inter-subject variability. Furthermore, 
nine patients (15%) were asymptomatic despite an 
FEV, of less than 50% of predicted normal value 
(poor perceivers). Six of these poor perceivers had no 
symptoms and FEV, less than 50% of predicted 
before the methacholine challenge test, and five of 
these were men. Rubinfield and Pain (10) made no 
comment of the gender of the other three poor 
perceivers. Other studies (11,12) did not find any 
gender differences in perception of dyspnoea and 
induced airway obstruction in asthmatic subjects. An 
alternate hypothesis is that men and women may 
differ in their psychological profile and attitude 
towards a chronic illness like bronchial asthma, 
which may affect their readiness to seek medical help 
in case of an acute exacerbation. The fact that there 
were more females who were taking corticosteroids 
prior to admission suggests that the difference in 
severity of asthma at presentation may be due to the 
way asthma was treated in the two groups, rather 
than a difference in the underlying severity of the 
disease. Although there was no difference in duration 
of symptoms prior to presentation between the two 
groups, there was a trend towards more females with 
symptoms for less than 24 h prior to presentation 
(Table 1). This does suggest that males tend to wait 
longer before they present themselves to the ED for 
acute asthma. 
To the best of the authors’ knowledge, there are no 
reported studies addressing the severity of airflow 
obstruction between female and male asthmatic sub- 
jects presenting to the ED with acute asthma. There 
are two studies (13,14) which show that men tend to 
present more often with hypercapnea than women. In 
one study (13) of 229 (62 men, 167 women) consecu- 
tive admissions for acute asthma over 6 yr, Mountain 
and Sahn showed that 50% of men with acute asthma 
had hypercapnea compared with only 18% of 
women. Men also had a higher mean PaCO, on 
admission than did women (43 mmHg vs. 34 mmHg). 
No comparisons were made in lung function tests 
between men and women. Furthermore, there are 
some reports from Canada and the U.K. (4,15) which 
show higher rates of death from asthma among 
young males aged 15-34 years. However, there was 
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no difference in asthma mortality between females 
and males in New Zealand (16). 
In summary, it has been shown that in the authors’ 
ED there is a high female:male ratio among patients 
presenting with acute asthma, and males tend to 
present later or with more severe disease. This differ- 
ence in severity of asthma at presentation may be due 
to physiological, psychological factors, or a combi- 
nation of both, or a difference in the way the therapy 
for asthma is prescribed or taken. If this difference is 
re-reproduced in a larger prospective study, and in 
view of higher mortality rates among young males 
than young females in some reports, young males 
with asthma should be considered at higher risk of 
dying from asthma and targeted more, especially 
with asthma education (17). 
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